Physician profile
James P Marro
NPI 1588649446
$3,245.89
in general payments reported to CMS, 2019-2025
14 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $91.60 · 2021: $276 · 2022: $231 · 2023: $71.57 · 2024: $77.29 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,097 · Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.52 |
| Food and Beverage | $346.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,519.53 | 2019-2024 | T2, Gamma |
| Peerless Surgical INC. | $841.34 | 2024-2025 | |
| Arthrex, INC. | $482.45 | 2025 | |
| Heron Therapeutics, INC. | $104.88 | 2021-2022 | |
| Silk Road Medical, INC. | $79.93 | 2020 | |
| Bioventus LLC | $52.35 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $45.11 | 2022-2023 | Exparel, Zilretta, Iovera |
| Ermi LLC | $35.06 | 2019 | |
| Solventum Corporation | $16.91 | 2025 | Activ.A.C. |
| Linvatec Corporation | $15.52 | 2019 | |
| Osteoremedies, LLC | $14.12 | 2024 | Osteoboost Select 10cc, Biobrush, Biowash Surgical Irrigation |
| Medtronic, INC. | $14.08 | 2023 | Plasmablade(Tm) |
| Abbvie INC. | $12.94 | 2022 | |
| Merck Sharp & Dohme LLC | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Marro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.